Nihon Kohden (OTCMKTS:NHNKY) Upgraded by UBS Group to “Strong-Buy” Rating

UBS Group upgraded shares of Nihon Kohden (OTCMKTS:NHNKY) from a hold rating to a strong-buy rating in a research report released on Monday morning,Zacks.com reports.

Nihon Kohden Price Performance

OTCMKTS:NHNKY opened at $11.92 on Monday. The company has a market capitalization of $2.04 billion, a PE ratio of 16.33 and a beta of 0.41. Nihon Kohden has a 1-year low of $9.23 and a 1-year high of $17.28. The firm’s 50-day moving average price is $10.77 and its 200-day moving average price is $11.44.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Monday, November 10th. The company reported $0.18 earnings per share (EPS) for the quarter. The firm had revenue of $394.01 million during the quarter. Nihon Kohden had a net margin of 7.78% and a return on equity of 9.28%.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.